Melanosis Vulvar, lesion de aspecto aparatoso, pero de bajo riesgo.
Benign vulvar melanosis can appear alarming on clinical exam because it is often darkly pigmented or even black, and many patients are unaware of its presence and cannot provide history regarding change or stability. The authors performed an excellent study outlining the key dermoscopic features of vulvar melanosis, especially with regard to features which differentiate it from vulvar melanoma.
The authors found that, if on dermoscopy a pigmented vulvar lesion is either a homogenous or non-homogenous black or brown color, lacks red, gray, or blue colors, and/or lacks typical dermoscopic parameters for melanocytic lesions (pigment network, dots and globules, pseudopods, and streaks), the clinician can diagnose vulvar melanosis with confidence and avoid biopsy. Most importantly, none of their patients with vulvar melanosis developed melanoma during the 20-year follow-up period, indicating that vulvar melanosis is indeed a benign entity with an extremely low risk of malignant transformation.
Although a small number of patients with vulvar melanosis in this study eventually developed an inflammatory vulvar dermatosis (such as lichen sclerosus), I personally see a large number of patients with either active or previously active inflammatory vulvar diseases who have vulvar melanosis; so, perhaps future studies are warranted to confirm this association.
Importance
Vulvar melanosis is a common pigmentary change that accounts for most pigmented vulvar lesions. It presents as single or multiple asymptomatic macules or patches of varying size and color that may be asymmetric with poorly defined borders. The differential diagnosis of melanocytic lesions includes melanoma, which creates anxiety for patients and the physicians who diagnose the condition and treat the patients.
Objective
To evaluate the clinical and dermoscopic features of vulvar melanosis and their changes over time.
Design, Setting, and Participants
In this cohort study, patients with vulvar melanosis were recruited and followed up in the Department of Dermatology, University of Florence, Florence, Italy, between January 1, 1998, and June 30, 2019. Data on patient characteristics and on both the clinical and dermoscopic features of the vulvar lesions were collected. Each lesion was photographed clinically and dermoscopically at initial evaluation and at annual follow-up visits.
Main Outcomes and Measures
The clinical, dermoscopic, and histopathologic features of vulvar melanosis and their changes over time.
Results
This cohort study included 129 women (mean age at diagnosis, 46 years [range, 19-83 years]) with vulvar melanosis. A total of 87 patients (67%) with vulvar melanotic lesions were premenopausal, and 84 patients (65%) had received some type of hormone therapy. The most frequent location for vulvar melanosis was the labia minora (55 [43%]), followed by the labia majora (33 [26%]). In 39 of 129 cases (30%), the lesions increased in size and changed color after initial evaluation but ultimately stabilized. No malignant evolution was documented in any patient during a median follow-up of 13 years (range, 5-20 years).
Conclusions and Relevance
This study suggests that vulvar melanosis was a benign entity, and changes in lesions over time did not signify malignant transformation. An association between hormonal status and vulvar melanosis may be hypothesized.
0 Comments:
Post a Comment
Subscribe to Post Comments [Atom]
<< Home